Calla Lily Clinical Care awarded Innovate UK grant to expand Callavid® platform for vaginal microbiome health
Calla Lily Clinical Care, a clinical-stage women's health company, today announced it has been awarded a £700 k Innovate UK grant through its Growth Catalyst: Investor Partnerships program, which pairs grant funding with matched private investment.
Read original article on The Medical News →